General Information of Drug Off-Target (DOT) (ID: OTCQ8DAD)

DOT Name Migration and invasion enhancer 1 (MIEN1)
Synonyms HBV X-transactivated gene 4 protein; HBV XAg-transactivated protein 4; Protein C35
Gene Name MIEN1
Related Disease
Adenocarcinoma ( )
Breast lobular carcinoma ( )
Breast neoplasm ( )
Colon cancer ( )
Colon carcinoma ( )
Colorectal carcinoma ( )
Oral cancer ( )
Breast cancer ( )
Metastatic malignant neoplasm ( )
Neoplasm ( )
Gastric neoplasm ( )
Breast carcinoma ( )
Systemic lupus erythematosus ( )
UniProt ID
MIEN1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
2LJK
Pfam ID
PF10262
Sequence
MSGEPGQTSVAPPPEEVEPGSGVRIVVEYCEPCGFEATYLELASAVKEQYPGIEIESRLG
GTGAFEIEINGQLVFSKLENGGFPYEKDLIEAIRRASNGETLEKITNSRPPCVIL
Function
Increases cell migration by inducing filopodia formation at the leading edge of migrating cells. Plays a role in regulation of apoptosis, possibly through control of CASP3. May be involved in a redox-related process.
Tissue Specificity
Among normal tissues, present only in Leydig cells. Strongly up-regulated in breast cancers and in brain cancer distant metastasis (at protein level). Up-regulated in prostate cancer cells and in the higher grades of prostate adenocarcinoma (at protein level).

Molecular Interaction Atlas (MIA) of This DOT

13 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Adenocarcinoma DIS3IHTY Strong Altered Expression [1]
Breast lobular carcinoma DISBY98Q Strong Altered Expression [2]
Breast neoplasm DISNGJLM Strong Biomarker [3]
Colon cancer DISVC52G Strong Altered Expression [4]
Colon carcinoma DISJYKUO Strong Altered Expression [4]
Colorectal carcinoma DIS5PYL0 Strong Altered Expression [5]
Oral cancer DISLD42D Strong Biomarker [6]
Breast cancer DIS7DPX1 moderate Biomarker [3]
Metastatic malignant neoplasm DIS86UK6 moderate Altered Expression [7]
Neoplasm DISZKGEW moderate Altered Expression [3]
Gastric neoplasm DISOKN4Y Disputed Genetic Variation [8]
Breast carcinoma DIS2UE88 Limited Biomarker [3]
Systemic lupus erythematosus DISI1SZ7 Limited Genetic Variation [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the expression of Migration and invasion enhancer 1 (MIEN1). [10]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Migration and invasion enhancer 1 (MIEN1). [11]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Migration and invasion enhancer 1 (MIEN1). [12]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Migration and invasion enhancer 1 (MIEN1). [13]
Ivermectin DMDBX5F Approved Ivermectin decreases the expression of Migration and invasion enhancer 1 (MIEN1). [14]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Migration and invasion enhancer 1 (MIEN1). [15]
Cannabidiol DM0659E Approved Cannabidiol decreases the expression of Migration and invasion enhancer 1 (MIEN1). [16]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Migration and invasion enhancer 1 (MIEN1). [18]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Migration and invasion enhancer 1 (MIEN1). [17]
------------------------------------------------------------------------------------

References

1 Migration and Invasion Enhancer 1 Is an NF-B-Inducing Gene Enhancing the Cell Proliferation and Invasion Ability of Human Prostate Carcinoma Cells In Vitro and In Vivo.Cancers (Basel). 2019 Oct 2;11(10):1486. doi: 10.3390/cancers11101486.
2 C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer.Mol Cancer Ther. 2006 Nov;5(11):2919-30. doi: 10.1158/1535-7163.MCT-06-0389.
3 CRISPR deletion of MIEN1 in breast cancer cells.PLoS One. 2018 Oct 4;13(10):e0204976. doi: 10.1371/journal.pone.0204976. eCollection 2018.
4 miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition.Onco Targets Ther. 2017 Dec 22;11:67-74. doi: 10.2147/OTT.S113359. eCollection 2018.
5 C35 is overexpressed in colorectal cancer and is associated tumor invasion and metastasis.Biosci Trends. 2015 Apr;9(2):117-21. doi: 10.5582/bst.2015.01057.
6 MIEN1 promotes oral cancer progression and implicates poor overall survival.Cancer Biol Ther. 2015;16(6):876-85. doi: 10.1080/15384047.2015.1040962.
7 MIEN1, a novel interactor of Annexin A2, promotes tumor cell migration by enhancing AnxA2 cell surface expression.Mol Cancer. 2015 Aug 15;14:156. doi: 10.1186/s12943-015-0428-8.
8 MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain.Int J Oncol. 2003 Jun;22(6):1369-74.
9 Transancestral mapping and genetic load in systemic lupus erythematosus.Nat Commun. 2017 Jul 17;8:16021. doi: 10.1038/ncomms16021.
10 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
11 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
12 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
13 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
14 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
15 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
16 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
17 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
18 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.